{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:10:39Z","timestamp":1791166239706,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chemo-radiotherapy with curative intent for anal cancer has high complete remission rates, but acute treatment-related gastrointestinal (GI) toxicity is significant. Toxicity occurs due to irradiation of surrounding normal tissue. Current radiotherapy requires the addition of large planning margins to the radiation field to ensure target coverage regardless of the considerable organ motion in the pelvic region. This increases the irradiated volume and radiation dose to the surrounding normal tissue and thereby toxicity. Online adaptive radiotherapy uses artificial intelligence to adjust the treatment to the anatomy of the day. This allows for the reduction of planning margins, minimizing the irradiated volume and thereby radiation to the surrounding normal tissue.This study examines if cone beam computed tomography (CBCT)-guided oART with daily automated treatment re-planning can reduce acute gastrointestinal toxicity in patients with anal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods\/design<\/jats:title>\n                    <jats:p>The study is a prospective, single-arm, phase II trial conducted at Copenhagen University Hospital, Herlev and Gentofte, Denmark. 205 patients with local only or locally advanced anal cancer, referred for radiotherapy with or without chemotherapy with curative intent, are planned for inclusion. Toxicity and quality of life are reported with Common Terminology Criteria of Adverse Events and patient-reported outcome questionnaires, before, during, and after treatment. The primary endpoint is a reduction in the incidence of acute treatment-related grade\u2009\u2265\u20092 diarrhea from 36 to 25% after daily online adaptive radiotherapy compared to standard radiotherapy. Secondary endpoints include all acute and late toxicity, overall survival, and reduction in treatment interruptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Accrual began in January 2022 and is expected to finish in January 2026. Primary endpoint results are expected to be available in April 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This is the first study utilizing online adaptive radiotherapy to treat anal cancer. We hope to determine whether there is a clinical benefit for the patients, with significant reductions in acute GI toxicity without compromising treatment efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov Identifier: NCT05438836. Danish Ethical Committee: H-21028093<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-024-12111-1","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T05:01:59Z","timestamp":1711342919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol"],"prefix":"10.1186","volume":"24","author":[{"given":"Katrine Smedegaard","family":"Storm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina M","family":"\u00c5str\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Sibolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus P","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte F","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Serup-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"12111_CR1","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/ije\/dyx200","volume":"46","author":"F Islami","year":"2017","unstructured":"Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A. International trends in anal cancer incidence rates. Int J Epidemiol. 2017;46:924\u201338.","journal-title":"Int J Epidemiol"},{"key":"12111_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial. Lancet Oncol. 2013;14:516\u201324.","journal-title":"Lancet Oncol"},{"key":"12111_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated Radiation Therapy in Combination with 5-Fluorouracil and Mitomycin-C for the reduction of Acute Morbidity in Carcinoma of the Anal Canal. Int J Radiation Oncology*Biology*Physics. 2013;86:27\u201333.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"12111_CR4","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","volume":"348","author":"Epidermoid anal cancer","year":"1996","unstructured":"Epidermoid anal cancer. : results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet. 1996;348:1049\u201354.","journal-title":"Lancet"},{"key":"12111_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","volume":"32","author":"S Rao","year":"2021","unstructured":"Rao S, Guren MG, Khan K, Brown G, Renehan AG, Steigen SE, et al. Anal cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up(\u2606). Ann Oncol. 2021;32:1087\u2013100.","journal-title":"Ann Oncol"},{"key":"12111_CR6","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastro. J Clin Oncol. 1997;15:2040\u20139.","journal-title":"J Clin Oncol"},{"key":"12111_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.radonc.2014.10.002","volume":"113","author":"O Leon","year":"2014","unstructured":"Leon O, Guren M, Hagberg O, Glimelius B, Dahl O, Havsteen H, et al. Anal carcinoma \u2013 survival and recurrence in a large cohort of patients treated according to nordic guidelines. Radiother Oncol. 2014;113:352\u20138.","journal-title":"Radiother Oncol"},{"key":"12111_CR8","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","volume":"28","author":"E Ben-Josef","year":"2010","unstructured":"Ben-Josef E, Moughan J, Ajani JA, Flam M, Gunderson L, Pollock J, et al. Impact of overall treatment time on survival and local control in patients with Anal Cancer: a Pooled Data Analysis of Radiation Therapy Oncology Group trials 87 \u2013\u200904 and 98 \u2013\u200911. J Clin Oncol. 2010;28:5061\u20136.","journal-title":"J Clin Oncol"},{"key":"12111_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/0284186X.2013.770599","volume":"52","author":"AG Bentzen","year":"2013","unstructured":"Bentzen AG, Balteskard L, Wander\u00e5s EH, Frykholm G, Wilsgaard T, Dahl O, et al. Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol. 2013;52:736\u201344.","journal-title":"Acta Oncol"},{"key":"12111_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.radonc.2013.05.037","volume":"108","author":"AG Bentzen","year":"2013","unstructured":"Bentzen AG, Guren MG, Vonen B, Wander\u00e5s EH, Frykholm G, Wilsgaard T, et al. Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort. Radiother Oncol. 2013;108:55\u201360.","journal-title":"Radiother Oncol"},{"key":"12111_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ijrobp.2014.06.061","volume":"90","author":"K Han","year":"2014","unstructured":"Han K, Cummings BJ, Lindsay P, Skliarenko J, Craig T, Le LW, et al. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer. Int J Radiat Oncol Biol Phys. 2014;90:587\u201394.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12111_CR12","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00384-019-03342-x","volume":"34","author":"A Sterner","year":"2019","unstructured":"Sterner A, Derwinger K, Staff C, Nilsson H, Angenete E. Quality of life in patients treated for anal carcinoma\u2014a systematic literature review. Int J Colorectal Dis. 2019;34:1517\u201328.","journal-title":"Int J Colorectal Dis"},{"key":"12111_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.radonc.2022.09.015","volume":"176","author":"LM \u00c5str\u00f6m","year":"2022","unstructured":"\u00c5str\u00f6m LM, Behrens CP, Storm KS, Sibolt P, Serup-Hansen E. Online adaptive radiotherapy of anal cancer: normal tissue sparing, target propagation methods, and first clinical experience. Radiother Oncol. 2022;176:92\u20138.","journal-title":"Radiother Oncol"},{"key":"12111_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.radonc.2022.03.014","volume":"171","author":"LM \u00c5str\u00f6m","year":"2022","unstructured":"\u00c5str\u00f6m LM, Behrens CP, Calmels L, Sj\u00f6str\u00f6m D, Geertsen P, Mouritsen LS, et al. Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: initial experience and dosimetric benefits. Radiother Oncol. 2022;171:37\u201342.","journal-title":"Radiother Oncol"},{"key":"12111_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phro.2020.12.004","volume":"17","author":"P Sibolt","year":"2021","unstructured":"Sibolt P, Andersson LM, Calmels L, Sj\u00f6str\u00f6m D, Bjelkengren U, Geertsen P, et al. Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region. Phys Imaging Radiat Oncol. 2021;17:1\u20137.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"12111_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.radonc.2022.08.026","volume":"175","author":"JP Schiff","year":"2022","unstructured":"Schiff JP, Price AT, Stowe HB, Laugeman E, Chin RI, Hatscher C, et al. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer. Radiother Oncol. 2022;175:144\u201351.","journal-title":"Radiother Oncol"},{"key":"12111_CR17","first-page":"100596","volume":"40","author":"CE Shelley","year":"2023","unstructured":"Shelley CE, Bolt MA, Hollingdale R, Chadwick SJ, Barnard AP, Rashid M, et al. Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer. Clin Transl Radiat Oncol. 2023;40:100596.","journal-title":"Clin Transl Radiat Oncol"},{"key":"12111_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.phro.2022.04.009","volume":"22","author":"LGM Zwart","year":"2022","unstructured":"Zwart LGM, Ong F, Ten Asbroek LA, Van Dieren EB, Koch SA, Bhawanie A, et al. Cone-beam computed tomography-guided online adaptive radiotherapy is feasible for prostate cancer patients. Phys Imaging Radiat Oncol. 2022;22:98\u2013103.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"12111_CR19","doi-asserted-by":"crossref","unstructured":"De Jong R, Visser J, Van Wieringen N, Wiersma J, Geijsen D, Bel A. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer. Radiat Oncol. 2021;16.","DOI":"10.1186\/s13014-021-01866-7"},{"key":"12111_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tipsro.2022.04.001","volume":"22","author":"L Calmels","year":"2022","unstructured":"Calmels L, Sibolt P, \u00c5str\u00f6m LM, Serup-Hansen E, Lindberg H, Fromm A-L, et al. Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer. Tech Innov Patient Support Radiat Oncol. 2022;22:30\u20136.","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"12111_CR21","doi-asserted-by":"crossref","unstructured":"De Jong R, Crama KF, Visser J, Van Wieringen N, Wiersma J, Geijsen ED et al. Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit. Radiat Oncol. 2020;15.","DOI":"10.1186\/s13014-020-01597-1"},{"key":"12111_CR22","doi-asserted-by":"crossref","unstructured":"Byrne M, Archibald-Heeren B, Hu Y, Teh A, Beserminji R, Cai E et al. Varian ethos online adaptive radiotherapy for prostate cancer: early results of contouring accuracy, treatment plan quality, and treatment time. J Appl Clin Med Phys. 2022;23.","DOI":"10.1002\/acm2.13479"},{"key":"12111_CR23","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, et al. Elective clinical target volumes for conformal therapy in Anorectal Cancer: a Radiation Therapy Oncology Group Consensus Panel Contouring Atlas. Int J Radiation Oncology*Biology*Physics. 2009;74:824\u201330.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"12111_CR24","unstructured":"DACG. Target definition ved str\u00e5lebehandling af lokaliseret anal cancer. 2023;2023. https:\/\/dacgnet.dk\/wp-content\/uploads\/2023\/03\/dacg_target_def_primar_strale_lok_analc_v1.1_admgodk280223.pdf."},{"key":"12111_CR25","unstructured":"DACG. Onkologisk behandling af lokaliseret anal cancer. DMCG retningslinjer. 2019. https:\/\/www.dmcg.dk\/siteassets\/forside\/kliniske-retningslinjer\/godkendte-kr\/dacg_onkologisk-bh-lokaliseret-anal-cancer_admgodk181119.pdf. Accessed 14 May 2021."},{"key":"12111_CR26","first-page":"77","volume":"8","author":"Y Archambault","year":"2020","unstructured":"Archambault Y, Boylan C, Bullock D, Morgas T, Peltola J, Ruokokoski E, et al. Making on-line adaptive radiotherapy possible using artificial intelligence and machine learning for efficient daily re-planning. Med Phys Int J. 2020;8:77\u201386.","journal-title":"Med Phys Int J"},{"key":"12111_CR27","unstructured":"DACG. Opf\u00f8lgning efter onkologisk behandling af lokaliseret anal cancer. Dacgnet.dk. 2022;:15. https:\/\/dacgnet.dk\/wp-content\/uploads\/2022\/03\/dacg_opfolgning-e.-onkologisk-bh_v2.0_admgodk070122.pdf. Accessed 6 Oct 2023."},{"key":"12111_CR28","doi-asserted-by":"publisher","first-page":"jan08","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:jan08.","journal-title":"BMJ"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12111-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12111-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12111-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T17:40:35Z","timestamp":1711388435000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12111-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12111"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12111-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3511558\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is performed according to the Helsinki Declaration (Seoul version, October 2008) and Ethical Guidelines for Medical and Health Research Involving Human Subjects. The study protocol follows the SPIRIT guidelines [\n                      \n                      ]. It is approved by the Danish ethical committee (H-92389) and registered at clinicaltrials.gov (NCT05438836). All study participants give written informed consent before any study procedures are initiated.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors report institutional research and teaching contracts with Varian Medical Systems, ViewRay, and Brainlab outside of the submitted work. In addition, GP has received research funding from the Danish Comprehensive Cancer Center National Thematic Center on radiotherapy, the Danish Cancer Society, and the Danish Independent Research Fund. CB is a committee member for the Danish Comprehensive Cancer Center National Thematic Center on Radiotherapy, Nordic Association for Clinical Physics, and \u00d8resund workshop. ESH is a committee member of the Danish Anal Cancer Group.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"374"}}